Rhinebeck Bancorp, Inc. RBKB
12.83
(0.02)
(0.16%)
as of 25 Sep
- Market cap
- $200.9M
- P/E
- 17.8×
Follow RBKB
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
17.22 | 15.08 | 11.63 | 20.18 |
+8 more quarters Free account |
P/S ratio |
1.77 | 2.22 | 1.71 | 1.75 | |
P/FCF ratio |
10.06 | 16.61 | 11.88 | 10.50 | |
P/Operating CF |
24.00 | 47.55 | 46.86 | 55.10 | |
P/B ratio |
0.96 | 1.21 | 0.95 | 0.92 | |
Price to Tangible BV |
0.98 | 1.23 | 0.97 | 0.94 | |
EV/Sales |
(2.11) | 0.86 | 0.77 | 0.73 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(11.34) | 5.91 | 4.96 | 4.08 | |
EV/FCF |
(12.00) | 6.43 | 5.32 | 4.37 | |
Quick Ratio |
0.23 | 0.10 | 0.09 | 0.09 | |
Current Ratio |
0.94 | 0.93 | 0.94 | 0.95 | |
Net Debt/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
Debt/Assets |
0.70% | 0.80% | 2.33% | 2.41% | |
Debt/Equity |
0.07 | 0.07 | 0.22 | 0.24 | |
Asset Turnover |
0.06 | 0.06 | 0.06 | 0.05 | |
Operating CF/Net income |
2.14 | 1.59 | 1.19 | 0.83 | |
Capex/Depreciation |
(0.31) | (0.66) | (0.77) | (0.87) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
53.26% | 54.22% | 54.51% | 53.89% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.35% | 0.06% | 0.05% | 0.05% | |
Graham Net Nets |
(0.77) | (0.55) | (0.81) | (0.79) | |
Graham Number |
14.44 | 12.28 | 12.28 | 8.93 | |
Earnings Yield |
5.81% | 6.63% | 8.60% | 4.96% | |
Free Cash Flow Yield |
9.94% | 6.02% | 8.42% | 9.52% | |
Revenue per Share |
1.73 | 1.19 | 1.28 | 1.30 | |
Operating CF per Share |
0.52 | 0.23 | 0.18 | 0.15 | |
Capex per Share |
(0.01) | (0.01) | (0.02) | (0.01) | |
Free Cash Flow per Share |
0.51 | 0.22 | 0.16 | 0.14 | |
Cash per Share |
28.12 | 7.45 | 6.75 | 6.85 | |
Shareholders Equity per Share |
12.89 | 9.15 | 9.06 | 8.80 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
12.89 | 9.15 | 9.06 | 8.80 | |
Free Cash Flow |
5.51 | 3.33 | 2.45 | 2.05 | |
Working Capital |
(79.30) | (73.66) | (64.95) | (61.21) | |
Capital Expenditures |
(0.08) | (0.19) | (0.33) | (0.18) | |
Net Current Asset Value |
(102.82) | (91.86) | (104.66) | (97.05) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.01 | 0.02 | 0.01 | |
Net Profit Margin |
13.95% | 12.26% | 12.04% | 13.68% | |
Price to Operating Income |
10.74 | 13.27 | 10.24 | 19.14 | |
| Other line items | |||||
Average Payables |
1,176.89 | 1,068.87 | 1,059.06 | 1,081.00 | |
Average Assets |
1,372.15 | 1,270.40 | 1,278.77 | 1,291.08 | |
Average Common Equity |
134.28 | 132.31 | 129.34 | 127.84 |
Columns are period end dates